In short
- 🔑 An implant is a device with a shell inside a pocket. A biopolymer is loose material infiltrated into the tissue. That is the difference every other one follows from.
- An implant is removed whole. Injected material is rarely removed completely, because it does not form a pocket that can be emptied.
- An implant is a regulated medical device, with a manufacturer, a reference and traceability. A good part of the biopolymers injected were industrial-grade silicone or unidentified mixtures.
- ⚠️ An implant can also cause problems, and they are worth knowing about: rupture and silicone lymphadenopathy are the best documented.
- Silicone lymphadenopathy is usually silent. In a review of 279 cases, 33% were found incidentally and most were managed conservatively.
- ⚠️ On “breast implant illness” there is no definitive scientific link established, and the very papers that study it say so. What there is is described symptoms and research under way.
- If you are unsure what you have, it can be established. A surgical report, an implant card or an imaging scan clears it up.
It is a question that comes up a lot and almost always with fear behind it. Someone reads about biopolymers, sees the word “silicone”, remembers they have breast implants and the world falls in on them.
The short answer: no, they are not the same, and the difference is not a technical nuance. They are two different situations in everything that matters: what the material is, how it was placed, who placed it and what happens if it has to come out.
The long answer includes a part that also has to be said: an implant is not free of problems either. They are just different ones.
If what you have is injected material, the guide is the one on biopolymer removal. If what you have is an implant, the general information is in types of breast implant.
The four differences that matter
| Breast implant | Injected biopolymer | |
|---|---|---|
| What it is | A device with a shell containing the filling | Liquid or gel material with no shell, loose |
| Where it is | In a surgical pocket created for it, with defined boundaries | Infiltrated between fat, fascia and muscle, with no clear boundary |
| What product it is | A regulated medical device, with a manufacturer and a traceable reference | Frequently industrial-grade silicone or unidentified mixtures |
| On removal | It is removed whole, in a planned operation | It is rarely all removed: infiltrated tissue is resected |
That last row is what explains why this whole section of the site exists. Removing an implant is an operation with a clear, achievable objective. Removing a biopolymer is a resection whose result is, by definition, partial.
And one more difference, which is not technical
Who placed it and where.
A breast implant is placed in theatre, by a surgeon, at authorised healthcare premises, with a product that has a serial number and of which a record is kept. A good part of the biopolymers we see in the consulting room were injected outside all of that: in homes, in non-medical premises, without the product being identified and with no record at all.
It is not a judgement on whoever had them — the reason is usually access rather than recklessness — but it does explain why in one case you know exactly what is inside and in the other you do not. The page on what substances lie behind the word goes into it.
An implant is not harmless either, and it is worth saying
Not being a biopolymer does not make it something with no possible consequences. An implant is a medical device, it has complications of its own that are described, and one of them has to do with imaging, which is what this page is about. It goes in a few lines and with its context: none of these situations resembles what happens with infiltrated material, not in frequency, not in severity, and not in what can be done afterwards.
Rupture and silicone lymphadenopathy
When a silicone implant ruptures, the material can migrate to nearby lymph nodes. That is what is called silicone lymphadenopathy, and a systematic review of the literature with 279 cases describes well how it behaves:
| Found incidentally | 33% |
| Commonest symptom | A painless enlarged node |
| Patients with a silicone implant | 95% |
| Patients with a ruptured implant | 68% |
| Most affected region | The axilla (72%), followed by internal mammary, cervical and mediastinal |
| Management | Mostly conservative |
The conclusion of that review is the one worth holding on to: most patients are asymptomatic and most cases are managed conservatively. A minority need a biopsy or surgery, generally because of an abnormal scan, persistent symptoms or a ruptured implant.
There is one point of contact with the rest of this section worth noting: just like injected material, silicone in a lymph node can confound an imaging scan. If you have implants and an enlarged node is being investigated, say so.
And “breast implant illness”, in two lines
It is a term you will come across while searching, so it is worth knowing where it stands: there is no definitive scientific link established, the authors of the most recent systematic review say so expressly, and the entity still has no agreed definition. It is an open debate, with small observational studies, and it is not this page’s subject. If you have implants and it worries you, it is a conversation for the consulting room with whoever operates on you, not something to be settled by reading.
What is this page’s subject, and why it is said here: none of the above has anything to do with biopolymers, or the other way round. An implant is a regulated medical device, with a shell, with a serial number, placed in theatre and removable whole. A biopolymer is injected material that infiltrates the tissue, which often nobody even knows the identity of, and which is not removed: it is resected along with the tissue it is in. They are two different things, with different literature and different outcomes, and putting them in the same sentence helps nobody.
And if I do not know what I have?
It is more common than it seems, especially if the surgery was years ago or in another country. It can be established:
- The surgical report. It should state what was placed. It is your clinical record and you are entitled to a copy.
- The implant card or label, which identifies the manufacturer and reference.
- An imaging scan. An implant and infiltrated material look nothing alike on an ultrasound or an MRI. It is in the imaging diagnosis page.
Book an appointment
You can book your own appointment. Pick the day and time from the free slots in the diary, in a panel that opens right here, without leaving this page.
Frequently asked questions
I have breast implants. Do I have biopolymers?
No. An implant is a device with a shell placed in a surgical pocket and removable whole; a biopolymer is loose material infiltrated into the tissue. They are not the same situation and they are not managed the same way.
But they are both silicone, aren’t they?
The name coincides and little else. An implant is a regulated medical device, with a manufacturer and a reference; a good part of what was injected as “biopolymer” was industrial-grade silicone or unidentified mixtures, and it goes in loose rather than contained.
Should I have my implants out just in case?
That is not a recommendation that follows from having implants. Decisions about explantation are taken for specific reasons — rupture, symptoms, a change of plan — and are assessed individually.
They have found a lymph node and I have implants. Is it serious?
It may be silicone lymphadenopathy, which in most cases is asymptomatic and managed conservatively. What matters is that whoever interprets the scan knows you have implants.
And if I was injected with something as well as the implants?
It happens, and it is a situation worth clarifying with imaging, because the management of each is different. There are cases in the literature of the unexpected finding of injected material during implant revision surgery.
Can an implant be placed where there were biopolymers?
It is assessed, and it depends on the state of the tissue and on the history of inflammation. It is covered on the reconstruction page.
Do implants cause autoimmune diseases?
There is no definitive scientific link established, and the very papers studying the subject say so. There are symptoms described more frequently in people with implants and there is research under way; there is no demonstrated causal relationship.
Where do I look if what I want is information about implants?
In types of breast implant and in differences between round and anatomical implants.
Sources
- Pelegrina Perez TC, Desai A, Tadisina KK, Singh DP, Kesmodel SB, Rojas KE, Mella-Catinchi JR. Prevalence, clinical characteristics, and management of silicone lymphadenopathy: A systematic review of the literature. J Plast Reconstr Aesthet Surg. 2024;90:76-87. A systematic review of 101 studies with 279 cases of silicone lymphadenopathy; of the 107 with information on the initial diagnosis, 35 (33%) were incidental; the commonest symptom was a painless enlarged node; 95% of patients had silicone implants and 68% had a ruptured implant; the most affected region was the axilla (72%), followed by internal mammary (21%), cervical or supraclavicular (19%) and mediastinal (13%); most patients are asymptomatic and most cases are managed conservatively, with biopsy and surgery reserved for an abnormal scan, persistent symptoms or rupture. https://pubmed.ncbi.nlm.nih.gov/38364672/
- Simon E, Pahus L, Chanez P. Pulmonary adverse events of breast silicone implants and silicone injection. Respir Med Res. 2023;84:101065. The overall prevalence of adverse effects is around 20% and the true incidence of pulmonary ones is unknown; some subpopulations appear to be at greater risk, in particular asthmatic patients, in whom implants might contribute to worse control of the disease. https://pubmed.ncbi.nlm.nih.gov/38042060/
- Bouhadana G, Boucher C, Saleh E, Gornitsky J, Borsuk DE. Defining Breast Implant Illness: A Systematic Review and Meta-analysis of Patient-reported Symptoms. Plast Reconstr Surg Glob Open. 2025;13:e6773. A systematic review and meta-analysis of 36 articles with 10,519 patients; the authors expressly note that no definitive scientific link has been established; the symptoms most associated with the presence of implants were fatigue or malaise (RR 3.15), myalgia or weakness (RR 2.96) and cognitive dysfunction (RR 2.87); ruptured implants (RR 1.12) or silicone-filled ones (RR 2.11) were associated with more symptoms, while explantation (RR 0.94) and a cosmetic indication (RR 0.91) were associated with fewer. https://pubmed.ncbi.nlm.nih.gov/40391348/
- Bruno A, Foti R. Breast Implant Illness Symptom Resolution Over 24 Months After Explantation: A Prospective Observational Study. Aesthetic Plast Surg. 2026;50:4009-4018. A single-centre prospective observational study of 20 women having implants removed for suspected breast implant illness, with follow-up to 24 months; every symptom group improved significantly from baseline; musculoskeletal symptoms improved fastest, with substantial reductions at 3 months, followed by neurocognitive ones at 6 months; fatigue improved more gradually, stabilising at 12 months, and dermatological symptoms followed the slowest trajectory, with maximum improvement between 18 and 24 months; a longer implant duration correlated with slower neurocognitive recovery. Level of evidence IV. https://pubmed.ncbi.nlm.nih.gov/41813982/
- Moris V. Intraoperative Discovery of Permanent Gluteal Filler During Implant Revision: A Case Report on Surgical Adaptation and Risk Awareness. Am J Case Rep. 2026;27:e950406. Unexpected intraoperative finding of gelatinous material consistent with permanent filler during revision of a gluteal augmentation, which forced the procedure to be adapted in the same session. https://pubmed.ncbi.nlm.nih.gov/41787771/
Book your consultation
If you have come here frightened about a set of implants, the likeliest thing is that your situation has nothing to do with what is described in the rest of this section.
And if you genuinely do not know what you have — because the surgery was a long time ago or somewhere else — that can be established: with the surgical report, with the implant card or with an imaging scan.
Clinical confirmation by the surgeon
Registration no. 46/4624077
Registration no. 46/4624503
Last reviewed: 6 September 2026. This content is for information only and does not replace an individual assessment by a healthcare professional.
